Following a customer-centric approach, the main objective of VIVEbiotech’s Technological Innovation Department is to develop the most productive, functional and regulatory-compliant vector before the production phase in bioreactors.
Improve producer cell lines, including the possibility of genetic modification to:
Enhance productivity.
Increase tropism.
Optimize expansion.
Obtain a stable cell line.
Develop new analytical methods to:
Better understand our process and/or product.
Improve analytical methods for batch release.
Different pseudotyping strategies.
Lentisoma.
Worldwide licensed technology (WO 2015/078999 A1) consisting of a non-integrative episomal stable lentiviral vector that provides a lasting, stable, consistent expression of the transgene in dividing and non-dividing cells.
Gestionar consentimiento
We use cookies to optimise our website and our service.
Functional
Always active
The storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
El almacenamiento o acceso técnico es necesario para la finalidad legítima de almacenar preferencias no solicitadas por el abonado o usuario.
Statistics
Technical storage or access that is used exclusively for statistical purposes.El almacenamiento o acceso técnico que se utiliza exclusivamente con fines estadísticos anónimos. Sin un requerimiento, el cumplimiento voluntario por parte de tu proveedor de servicios de Internet, o los registros adicionales de un tercero, la información almacenada o recuperada sólo para este propósito no se puede utilizar para identificarte.
Marketing
Technical storage or access is necessary to create user profiles to send advertising, or to track the user across a website or across multiple websites for similar marketing purposes.
